Colorectal cancer (CRC) is the leading cause of cancer deaths around the world. It is
necessary to identify patients with poor prognosis or with high risk for recurrence so that we …

Background Inflammation may play an important role in cancer progression, and a high
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …

There is increasing and consistent evidence that cancer-associated inflammation is a key
determinant of outcome in patients with cancer. Various markers of inflammation have been …

Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are
increasingly being recognised as having an important role in tumorigenesis and …

The prognostic role of inflammation index like neutrophil‐to‐lymphocyte ratio (NLR) in
colorectal cancer (CRC) remains controversial. We conduct a meta‐analysis to determine …

Background: The neutrophil-lymphocyte ratio (NLR) has been proposed as an indicator of
systemic inflammatory response. Previous findings from small-scale studies revealed …

Background Inflammation is a hallmark of cancer, and systemic markers of inflammation are
increasingly recognised as negative prognostic factors for clinical outcome. Neutrophil‐to …

Introduction There is increasing evidence to suggest that cancer-associated inflammation is
associated with poorer long-term outcomes. Various markers have been studied over the …

BACKGROUND AND OBJECTIVES The detection of a simple and reliable prognostic
biomarker for colorectal cancer (CRC) outcomes remains a significant challenge. The use of …

The tremendous success of immunotherapy in clinical trials has led to its establishment as a
new pillar of cancer therapy. However, little clinical efficacy has been achieved in …